After adjusting for sex, age at treatment initiation, initial tumor size, prolactin normalization, and number of affected pituitary axes, no significant difference was found in the recovery from hypogonadism between the two treatment groups (OR 1.633, 95% CI 0.616–4.4664, p = 0.338) (Table 3). Here, PRL is linked to neoplasm.